For the Inventor, By the Inventor

Enter assignee name

Pittsburgh, PA, United States of America

Chemimage Corporation

USPTO Granted Patents = 174

% Expired Patents = 12.6

Trademarks = 4

Forward Citations = 1,649

Loading Chart...

Loading Chart...

67 inventors (with patents filed for the assignee):

Patrick J Treado (107 out of 116 patents)

Matthew P Nelson (69 out of 71 patents)

John Maier (51 out of 56 patents)

4. Shona Stewart (29 out of 32 patents)

5. Charles W Gardner, Jr (25 out of 28 patents)

6. Robert Schweitzer (24 out of 27 patents)

7. David D Tuschel (24 out of 29 patents)

8. Jeffrey Cohen (22 out of 27 patents)

9. Jason Neiss (19 out of 19 patents)

10. Thomas Voigt (15 out of 19 patents)

11. Joseph E Demuth (13 out of 13 patents)

12. Scott Keitzer (12 out of 15 patents)

13. Heather Gomer (11 out of 11 patents)

14. Chenhui Wang (10 out of 11 patents)

15. G Steven Vanni (10 out of 11 patents)

Core Competencies:

Molecular Chemical Imaging

Hyperspectral Imaging

Raman Spectroscopy

Endoscopic Systems

Cardiac Monitoring

Explosives Detection

Spectral Processing

Chemical Imaging

Tissue Analysis

Optical Sensors

Pathogen Detection

Multi-Target Detection

174 patents: Sort by Forward Citations

1. 12369783 - Molecular chemical imaging endoscopic imaging systems (2025-07-29),

2. 12295743 - Quantification of heart failure using molecular chemical imaging (2025-05-13),

3. 12268355 - Discrimination of calculi and tissues with molecular chemical imaging (2025-04-08),

4. 12076162 - Systems and methods for detecting edema by fusing hyperspectral and visible image (2024-09-03),

5. 11982568 - Systems and methods foroptimization of tunable light emitting diode sources (2024-05-14),

6. 11980349 - Time correlated source modulation for endoscopy (2024-05-14),

7. 11935650 - Method for fusing sensor data for cardiac monitoring and devices thereof (2024-03-19),

8. 11741595 - Concealed substance detection with hyperspectral imaging (2023-08-29),

9. 11719985 - Non-mechanical multi-mode MCF/CF (2023-08-08),

10. 11699220 - Fusion of molecular chemical imaging with RGB imaging (2023-07-11),

11. 11668653 - Raman-based immunoassay systems and methods (2023-06-06),

12. 11607136 - System and method for conformal vision (2023-03-21),

13. 11598717 - Systems and methods for discrimination of tissue targets (2023-03-07),

14. 11568658 - Apparatus and methods for multi-target detection (2023-01-31),

15. 11525733 - Systems and methods of conformal spectral library training (2022-12-13),

Company Overview

Chemimage Corporation, based in Pittsburgh, PA, specializes in advanced molecular chemical imaging technologies. The company focuses on developing innovative solutions in hyperspectral imaging and Raman spectroscopy, catering to diverse applications such as endoscopic systems, cardiac monitoring, and explosives detection. With a commitment to enhancing spectral processing and chemical imaging, Chemimage plays a pivotal role in advancing analytical capabilities across various industries, contributing to improved safety and diagnostic precision.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

174 Patents

#22 in Pittsburgh, PA

#98 in Pennsylvania

#2,311 in US

#4,777 in the World

Pittsburgh, PA, United States of America

Chemimage Corporation

Forward Citations = 1,649

67 inventors:

Patrick J Treado (107 out of 116 patents)

Matthew P Nelson (69 out of 71 patents)

John Maier (51 out of 56 patents)

4. Shona Stewart (29 out of 32 patents)

5. Charles W Gardner, Jr (25 out of 28 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Chemimage Corporation. Retrieved from https://idiyas.com/company/chemimage

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…